Novavax Inc (NAS:NVAX)
$ 17.6401 2.6101 (17.37%) Market Cap: 2.60 Bil Enterprise Value: 1.97 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Novavax Inc Update Call Transcript

Dec 22, 2021 / 09:30PM GMT
Release Date Price: $183.3 (-4.07%)
Operator

Good day, and welcome to the Novavax COVID-19 vaccine Data Review Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Silvia Taylor, Senior VP of Global Corporate Affairs and Investor Relations. Please go ahead.

Silvia Taylor
Novavax, Inc. - SVP of Global Corporate Affairs & IR

Good evening, everyone, and thank you to all of you who have joined us for today's call to discuss Novavax' initial Omicron cross-reactivity data from our COVID-19 booster and adolescent studies. A press release announcing our results is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today.

Please also note that we have posted the slides that we are using during this evening's call at novavax.com/events.

Joining me today for discussion and a Q&A period are Stan Erck, President and CEO; Dr. Filip Dubovsky, Chief Medical Officer; Dr. Greg Glenn, President of R&D; and John Trizzino,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot